Search clinical trials for: Hydroxychloroquine tablets

Total 7016 results

Tasly Pharmaceutical Group Co., Ltd

Completed

Study of Jitongning Tablet to Treat Spondyloarthritis

Spondyloarthritis

China
Prof. Dr. Umar Farooq
Ayub Medical College, Abbottabad

Unknown

Effectiveness of Hydroxychloroquine in Covid-19 Patients (Covid)

COVID19

Pakistan
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism
Cardresearch
Cytel Inc.; Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA

Unknown

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

COVID-19 | Coronavirus Infection | SARS-CoV Infection | Acute Respiratory Infection | Virus Disease

Brazil
First Affiliated Hospital Xi'an Jiaotong University

Completed

Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease. (CHANGAN)

Coronary Artery Disease

China
Yiling Pharmaceutical Inc.

Completed

A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China

Parkinson Disease

China
General and Teaching Hospital Celje

Unknown

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Covid-19

Slovenia
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Not yet recruiting

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study (QUIgAN)

IgA Nephropathy

France
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects

Nonalcoholic Steatohepatitis (NASH)

China
The National Institutes of Pharmaceutical R&D Co...

Completed

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Idiopathic Pulmonary Fibrosis

United States
Shanghai First Maternity and Infant Hospital
Fudan University; Xinhua Hospital, Shanghai Jiao Tong University School of... and other collaborators

Not yet recruiting

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

Recurrent Miscarriage | Antiphospholipid Syndrome

China
Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Atridia Pty Ltd.

Completed

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Inflammatory Bowel Disease

Australia
GeoSentinel Foundation

Unknown

HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial (HERO)

COVID-19 | Prophylaxis | Hydroxychloroquine | Health Care Worker

United States
Harmony Biosciences, LLC

Active, not recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

Prader-Willi Syndrome

United States
Senyue Zhang

Completed

Acupuncture Combined With Hydroxychloroquine

Primary Sjögren's Syndrome

China
Lexicon Pharmaceuticals

Completed

A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Assiut University

Unknown

Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine) (HCQ)

Autoimmune Diseases
Dong Wha Pharmaceutical Co. Ltd.

Completed

The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

Diabetic Kidney Disease

Korea, Republic of
Ravi Amaravadi, MD

Terminated

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (PATCH)

COVID-19

United States
National University of Malaysia

Recruiting

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

Type 2 Diabetes | Diabetes in Pregnancy

Malaysia
First Affiliated Hospital of Harbin Medical University

Unknown

Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence

Atrial Fibrillation

China
Rigshospitalet, Denmark

Completed

The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.

Hyponatremia | Metabolic Bone Disease

Denmark
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Covid-19

Brazil
Radboud University Medical Center

Unknown

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Breast Cancer

Netherlands
Paratek Pharmaceuticals Inc

Active, not recruiting

Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Mycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary Infection

United States
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

COVID-19

Brazil
Sinew Pharma Inc.

Completed

Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers

Nonalcoholic Steatohepatitis

Taiwan
Sir Mortimer B. Davis - Jewish General Hospital

Withdrawn

Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women (HyPreC)

COVID-19 | Pregnant Women | SARS-CoV-2 | Hydroxychloroquine
Abderrahmane Mami Hospital
Eshmoun Clinical Research Center; Datametrix

Withdrawn

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals (COVID_2Pro)

COVID19 | Sars-CoV2 | Prophylaxis | Hydroxychloroquine | Healthcare Worker

Tunisia
Hansoh BioMedical R&D Company

Not yet recruiting

A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women

Vasomotor Symptoms

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses

Schizophrenia

Japan
Alkarkh Health Directorate-Baghdad

Completed

Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients

IMMUNOTHERAPY

Iraq
Valenta Pharm JSC

Recruiting

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Cholecystitis

Russian Federation
Cambridge University Hospitals NHS Foundation Trust

Unknown

PROLIFIC ChemoprophylaxisTrial (COVID-19)

COVID-19

United Kingdom
Fulcrum Therapeutics

Completed

Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets

Healthy Adult Subjects

United States
Overseas Pharmaceuticals, Ltd.
GX pharma technology (beijing) Co., Ltd

Active, not recruiting

An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.

Partial Seizure

China
Centre Hôpital Universitaire Farhat Hached

Unknown

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 (PACTT)

COVID-19 | SARS-CoV-2 Pneumonia

Tunisia
Vaxart

Completed

Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

Respiratory Syncytial Virus (RSV)

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Progressive Disease

United States
Beijing Tiantan Hospital
NeuroDawn Pharmaceutical Co., Ltd.

Recruiting

Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy (ESPRIT)

Ischemic Stroke, Acute

China
Damanhour University

Completed

Ivabradine in Patients With Congestive Heart Failure

Congestive Heart Failure

Egypt
Vaxart

Completed

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (VXA-NVV-103)

Norovirus Infection

United States
Ultragenyx Pharmaceutical Inc

Completed

Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)

Hereditary Inclusion Body Myopathy (HIBM)

United States
Peng Wang, MD PhD

Completed

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

Solid Tumor

United States
University of California, Los Angeles

Recruiting

Metformin Treatment in Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States
McGill University Health Centre/Research Institute...
University of Manitoba; University of British Columbia; University of Alberta; McMaster... and other collaborators

Terminated

Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)

Corona Virus Infection | SARS-CoV Infection | Coronavirus

United States, Canada

Search clinical trials for: Hydroxychloroquine tablets

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations